These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 24224933)

  • 1. XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks.
    Zaretzki J; Matlock M; Swamidass SJ
    J Chem Inf Model; 2013 Dec; 53(12):3373-83. PubMed ID: 24224933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. XenoSite server: a web-available site of metabolism prediction tool.
    Matlock MK; Hughes TB; Swamidass SJ
    Bioinformatics; 2015 Apr; 31(7):1136-7. PubMed ID: 25411327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DR-predictor: incorporating flexible docking with specialized electronic reactivity and machine learning techniques to predict CYP-mediated sites of metabolism.
    Huang TW; Zaretzki J; Bergeron C; Bennett KP; Breneman CM
    J Chem Inf Model; 2013 Dec; 53(12):3352-66. PubMed ID: 24261543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extending P450 site-of-metabolism models with region-resolution data.
    Zaretzki JM; Browning MR; Hughes TB; Swamidass SJ
    Bioinformatics; 2015 Jun; 31(12):1966-73. PubMed ID: 25697821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing better drugs: predicting cytochrome P450 metabolism.
    de Groot MJ
    Drug Discov Today; 2006 Jul; 11(13-14):601-6. PubMed ID: 16793528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate selectivity of drug-metabolizing cytochrome P450s predicted from crystal structures and in silico modeling.
    Dong D; Wu B
    Drug Metab Rev; 2012 Feb; 44(1):1-17. PubMed ID: 22242930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach.
    Korolev D; Balakin KV; Nikolsky Y; Kirillov E; Ivanenkov YA; Savchuk NP; Ivashchenko AA; Nikolskaya T
    J Med Chem; 2003 Aug; 46(17):3631-43. PubMed ID: 12904067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting the binding modes and sites of metabolism of xenobiotics.
    Mukherjee G; Lal Gupta P; Jayaram B
    Mol Biosyst; 2015 Jul; 11(7):1914-24. PubMed ID: 25913019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pragmatic approach using first-principle methods to address site of metabolism with implications for reactive metabolite formation.
    Hsiao YW; Petersson C; Svensson MA; Norinder U
    J Chem Inf Model; 2012 Mar; 52(3):686-95. PubMed ID: 22299574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of cytochrome P450 isoform responsible for metabolizing a drug molecule.
    Mishra NK; Agarwal S; Raghava GP
    BMC Pharmacol; 2010 Jul; 10():8. PubMed ID: 20637097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Docking Supplements an In vitro Determination of the Leading CYP Isoform for Arylpiperazine Derivatives.
    Ulenberg S; Bączek T; Zieliñska J; Belka M; Król M; Herold F
    Comb Chem High Throughput Screen; 2019; 22(6):370-378. PubMed ID: 31284855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational approaches for predicting CYP-related metabolism properties in the screening of new drugs.
    Crivori P; Poggesi I
    Eur J Med Chem; 2006 Jul; 41(7):795-808. PubMed ID: 16644065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human P450s involved in drug metabolism and the use of structural modelling for understanding substrate selectivity and binding affinity.
    Lewis DF; Ito Y
    Xenobiotica; 2009 Aug; 39(8):625-35. PubMed ID: 19514836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of amino acid residues participated in substrate recognition by cytochrome P450 subfamilies with broad substrate specificity.
    Zharkova MS; Sobolev BN; Yu Oparina N; Veselovsky AV; Archakov AI
    J Mol Recognit; 2013 Feb; 26(2):86-91. PubMed ID: 23334916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QNA-Based Prediction of Sites of Metabolism.
    Tarasova O; Rudik A; Dmitriev A; Lagunin A; Filimonov D; Poroikov V
    Molecules; 2017 Dec; 22(12):. PubMed ID: 29194399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
    Zhou SF; Liu JP; Chowbay B
    Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining structure- and ligand-based approaches to improve site of metabolism prediction in CYP2C9 substrates.
    Kingsley LJ; Wilson GL; Essex ME; Lill MA
    Pharm Res; 2015 Mar; 32(3):986-1001. PubMed ID: 25208877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational diversity and ligand tunnels of mammalian cytochrome P450s.
    Yu X; Cojocaru V; Wade RC
    Biotechnol Appl Biochem; 2013; 60(1):134-45. PubMed ID: 23587001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification of cytochrome P450 inhibitors and noninhibitors using combined classifiers.
    Cheng F; Yu Y; Shen J; Yang L; Li W; Liu G; Lee PW; Tang Y
    J Chem Inf Model; 2011 May; 51(5):996-1011. PubMed ID: 21491913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2D SMARTCyp reactivity-based site of metabolism prediction for major drug-metabolizing cytochrome P450 enzymes.
    Liu R; Liu J; Tawa G; Wallqvist A
    J Chem Inf Model; 2012 Jun; 52(6):1698-712. PubMed ID: 22631565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.